Ghana's Parliament last week passed a bill that will help to open up the country's hemp industry.The Narcotics Control Commission Amendment Bill 2023 authorises the Minister of Interior to grant licences and regulate the cultivation of cannabis. Often referred to as "wee" in Ghana, the type of plant that...

A bill relating to hemp products and production in Hawai'i has become law, without Governor Josh Green's signature.The Hawai'i Department of Agriculture (HDOA) issued the first licenses to growers under the State’s Industrial Hemp Pilot Program in the middle of 2018. Industrial hemp has the potential to bring significant...

Irritable Bowel Syndrome (IBS) has made it on to the qualifying condition list for medical cannabis eligibility in Ohio. But two other conditions that were petitioned have been rejected.The State Medical Board of Ohio this week agreed to include IBS on Ohio's list for medical marijuana, bringing the total...

Adult-use marijuana retailer sales in Massachusetts hit a new high in June, while medical marijuana sales in the state stagnate.According to information from the state's Cannabis Control Commission, retail sales reached $132.8 million in June 2023. The gross sales total since adult use retailers opened in late 2018 to...

Medigrowth, a leading Australian medicinal cannabis biotech, has announced a series of initiatives to advance the sector. The company is not only joining forces with Deakin University on clinical trial initiatives, it has plans to construct a Centre of Excellence in Geelong, and has launched a telehealth service, Haiku...

Australia's Bod Science Limited (ASX:BOD) has completed its phase IIB clinical trial for a potential Schedule 3 cannabidiol (CBD) product. But for the results, we'll need to wait a little longer.Carried out in partnership with sleep research organization the Woolcock Institute of Medical Research, the trial assessed the efficacy...

The Australian state of Victoria's Legislative Council Economy and Infrastructure Committee is seeking submissions for a comprehensive inquiry into the issues, barriers and opportunities currently affecting the state's hemp industry.On the 31st May 2023, a motion for the inquiry was passed in the Victorian Parliament, which instructs the committee...

The Minnesota Department of Health (MDH) has extended its medical cannabis program to include eligible patients diagnosed with irritable bowel syndrome (IBS) and obsessive-compulsive disorder (OCD).IBS is a  disorder characterised by abdominal discomfort or pain and erratic bowel movements, and its impact can be anywhere from inconvenient to debilitating....

The U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have jointly issued warning letters to six companies, alleging illegal marketing of copycat food products infused with Delta-8 tetrahydrocannabinol (Delta-8 THC).Like Delta-9, Delta-8 THC, has psychoactive and intoxicating effects. Delta-8 occurs naturally in hemp, but only...

There has been widespread positive reporting on the potential for medical cannabis to substitute prescription opioids and other non-opioid pain treatments. But a recent study found state laws permitting medical cannabis have had no significant effect on the use of such treatments among patients with chronic non-cancer pain.The study...